MedTrace Logo

A New 360° Dual-task Based Protocol for the Pre-clinical In-hospital and At-home Rehabilitation of Elderly: DUAL-Rehab

NCT06290167 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-08-04

No results posted yet for this study

Summary

The main objective of this project is two-fold

1. to develop a Dual-Task training exploiting the potentiality of the 360° technology in terms of interactivity and ecological validity
2. to investigate its efficacy in improving the cognitive functioning in a randomized clinical trial for 2 different populations: subjects with subjective memory complaints and mild cognitive impairment.

Specifically, participants will follow an integrated training including 2 phases: 1)in-hospital rehabilitation, where subjects will be provided sessions of the training in immersive modality; 2)at-home rehabilitation, where older adults will be asked to perform at home the non-immersive version of the training using a tablet.

Expected outcome is an improvement in cognitive functioning (assessed with a complete neuropsychological battery) after the training, thus advancing literature about non-pharmacological interventions in the preclinical stages of dementia along with innovative technical instruments.

Conditions

Interventions

DEVICE

360° media

sessions with head mounted display in hospital and sessions with tablet at home

OTHER

Treatment As Usual (TAU)

sessions of TAU rehabilitation in hospital and sessions TAU rehabilitation at home

OTHER

In hospital sessions

sessions will be carried out under the supervision of a therapist

OTHER

at home sessions

sessions will be carried out without the supervision of a therapist

OTHER

Mild Cognitive Impairment

half of this group will perform the protocol with 360° videos and the other half will perform the TAU

OTHER

Subjective Memory Complain

half of this group will perform the protocol with 360° videos and the other half will perform the TAU

Sponsors & Collaborators

  • Istituto Auxologico Italiano

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-03
Primary Completion
2026-04-10
Completion
2026-04-10

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06290167 on ClinicalTrials.gov